-
Study aim
-
Investigation of the effect of Midazolam and Dexmedetomidine injection on the effects of laminectomy under spinal anesthesia
-
Design
-
Clinical trial with a control group, with parallel groups, double-blind, randomized, phase 3 on 105 patients. Simple randomization tables are used for randomization
-
Settings and conduct
-
This study is a randomized double-blind clinical trial with a control group, the target population of which will be candidates for spinal laminectomy under spinal anesthesia at Al-Zahra Medical Center in Isfahan. Patients are distributed in three groups by simple random sampling. After placing on the operating table and performing spinal anesthesia on each group, one of the injected drug interventions, vital signs, and hemodynamic status of the patient before, during, and after surgery are controlled and recorded.
Interventional groups are coded, so the injector, clinical caregiver, surgeon, and patient are unaware of the injected intervention and are blind.
-
Participants/Inclusion and exclusion criteria
-
Patients between the ages of 18 and 65 who are candidates for laminectomy under spinal anesthesia who are in the ASA class of anesthesia I and II and do not have a specific underlying problem can enter the study.
-
Intervention groups
-
After the patient is placed on the operating table and connected to standard monitors, the patient undergoes spinal anesthesia. Then, in group A patients, 0.2 mg/kg / h of Midazolam was given, in group B patients, 0.1 μg / kg / h Dexmedetomidine, and in group C patients, 50 cc of normal saline will be infused per hour.
-
Main outcome variables
-
Blood Pressure; Heart Rate; Oxygen Saturation; Bleeding Rate; Surgeon satisfaction; Patient satisfaction